Searchable abstracts of presentations at key conferences in endocrinology

ea0014p256 | (1) | ECE2007

HRT in treatment of dislipidemia in women with hypogonadotropic hypogonadism

Zektser Vita , Ilovayskaya Irena , Iliyn Aleksandr , Goncharov Nikolay , Melnichenko Galina

Hypoestrogenemia is associated with dislipidemia and is an independent risk factor for cardiovascular diseases in postmenopausal women. However, there is a cohort of young women with gonadal steroid deficit caused by the disorders of central regulation. Twenty women with hypogonadotropic hypogonadism (HH) were included in group 1. (median age - 29 years and 3 months, median duration of amenorhea - 5 years 3 months, mean BMI - 24.6±6.05 kg/cm2. Women were examined before a...

ea0032p685 | Neuroendocrinology | ECE2013

Antipsychotic-induced hyperpolactinemia: clinical particulars and relation to sexual dysfunction

Yunilainen Olga , Starostina Elena , Dzeranova Larisa , Kolesnikova Galina , Kazia Gulnara , Goncharov Nikolay , Dedov Ivan

Objectives: To assess prevalence of antipsychotic-induced hyperpolactinemia (AIH) in psychiatric in-patients and to describe its clinical characteristics and association of AIH with sexual function.Methods: A cross-sectional study in 143 consecutive psychiatric in-patients (F/M=65/78), mostly with schizophrenia (93%), currently taking antipsychotics. The patients were screened for serum prolactin, sex hormones, gonadotropin levels and macroprolactin. For...

ea0022p484 | Female reproduction | ECE2010

Metabolic changes associated with hypogonadotropic hypogonadism in women of reproductive age and effect of HRT

Ilovayskaya Irena , Zektser Vita , Iljin Alexandr , Goncharov Nikolay , Melnichenko Galina , Dedov Ivan

We examined 56 normoprolactinemic women of reproductive age (18–45 y.o.) with isolated hypogonadotropic hypogonadism (group 1) initially and on treatment with 2 mg of 17β-estradiol and 10 mg of dydrogesterone in sequenced manner (HRT), duration of HRT was from 18 to 42 (median 36) months; 45 healthy women (20–38 y.o.) were included in control group 2.Initially hypercholesterolemia was observed in 50% of cases in group 1 and 6.6% in group 2...